durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['pace a']
safety is key in neoadjuvant space as these are patients can be cured with surgery. mainly low grade rashes. interestingly, 10% of patients on study got covid-19 (testament to clinical research sites staying open during covid-19) 
Professor, Medical Oncology @UCSD; PI @Patel_Lab computational immunopathology; Phase 1 & thoracic/NSCLC immunotherapy, solid tumor cell therapy, irAEs (he/him)